versiti
Dec 12, 2025, 06:35
Genotyping More Than 300,000 Blood Donors by Versiti
Versiti Blood Research Institute shared a post on LinkedIn:
“Incredible work by our colleagues across Versiti! This case is a powerful example of how decades of scientific investment (in this case, genotyping more than 300,000 blood donors) translates directly into lifesaving patient outcomes.”
Quoting Versiti Inc.’s post:
“In response to an urgent request from a major West Coast medical center, the National Blood Exchange reached out across member facilities, asking if any of them could quickly address a critical need for a patient. Versiti answered the call.
Read the full story.”
Follow the latest in Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch